SARS-CoV-2 3CLpro-IN-7

• UNSPSC Description:

  SARS-CoV-2 3CLpro-IN-7 is a reversible covalent SARS-CoV-2 3CL protease inhibitor with an IC50 value of 1.4 μM[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-3clpro-in-7.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC=C([N+]([O-])=O)C=C1)COC(/C(NC(C2=CC=CC=C2)=O)=C/C3=CC=C(Cl)C=C3)=O

• Molecular Weight:

  464.85

• References & Citations:

  [1]Wang L, et al. Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen. Eur J Med Chem. 2022 Dec 15;244:114803.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1164478-67-4